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Background: Cardiac MIBG imaging provides prognostic information in patients with chronic heart failure (CHF). Obesity, which is reported to 
potentiate the sympathetic activation, is associated with an increased risk of heart failure. Thus, we investigated whether obesity attenuates the 
prognostic value of cardiac MIBG imaging in CHF patients.
Method: We prospectively studied 112 consecutive CHF outpatients with LVEF<40%. All patients were classified into 2 groups according to the 
presence of obesity defined as baseline body mass index (≥25 kg/m2). The cardiac MIBG washout rate (WR) was calculated from the chest anterior 
view images obtained at 20 and 200 min after isotope injection. Abnormal WR was defined as >27%. The primary endpoint was  cardiac events (CE), 
including the hospitalization for the worsening of HF and cardiac death.
results: Twenty-six of 112 CHF patients had obesity. During the follow up period of 7.5±4.2 years, CE were observed in 53 of 112 patients. At 
multivariate Cox analysis, WR was a significant predictor of cardiac events in both obese (p=0.02) and non-obese patients (p=0.002). Kaplan-Meier 
analysis revealed that pts with abnormal WR had a significantly higher risk of CE than those with normal WR, in both obese (75% vs 36%, p=0.01, 
HR:3.8 (95% CI 1.3 to 11.5)) and non-obese groups (67% vs 22%, p<0.0001, HR:5.0 (95% CI 2.3 to 10.6)) .
conclusion: The Cardiac MIBG imaging would be useful to predict cardiac events in CHF patients, irrespective of the presence or absence of 
obesity.
